Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox ...

UCB, a global biopharmaceutical company, today announced that the final analysis of an open-label extension (OLE) study with ...

Incyte Canada Announces Health Canada approval of Opzelura® (Ruxolitinib) Cream for the ...

Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib phosphate)) ...